Anti-metastatic prostacyclins inhibit the adhesion of colon carcinoma to endothelial cells by blocking E-selectin expression

Clinical and Experimental Metastasis

Volumn 14, Issue 3, 1996, Pages 230-238

  Daneker, George W ^a   Lund, Serena A ^a   Caughman, S Wright ^a   Staley, Charles A ^a   Wood, William C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell adhesion molecules; Colon adenocarcinoma; Endothelium vascular; Metastasis models; Prostacyclins

Indexed keywords

BUCLADESINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FORSKOLIN; PROSTACYCLIN; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CANCER CELL; CELL ADHESION; CELL INTERACTION; COLON CARCINOMA; DRUG EFFECT; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; METASTASIS INHIBITION; PROTEIN SYNTHESIS INHIBITION;

1-METHYL-3-ISOBUTYLXANTHINE; ANTINEOPLASTIC AGENTS; BUCLADESINE; CARCINOMA; CELL ADHESION; CELLS, CULTURED; COLONIC NEOPLASMS; E-SELECTIN; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPOPROSTENOL; FORSKOLIN; HUMANS; NEOPLASM METASTASIS; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0030018263     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Gasic GJ, Gasic TB, Galanti N, Johnson T and Murphy S, 1973, Platelet-tumor cell interactions in mice. The role of platelets in the spread of malignant diseases. Int J Cancer, 11, 704-18.
2. Donati MB, Poggi A, Mussoni L, de Gaetano G and Garattini S, 1977, Hemostasis and experimental cancer dissemination. In: Day SB, Myers WPL, Stansley P, Garattini S and Lewis MG, eds. Cancer Invasion and Metastasis: biological mechanisms and therapy. New York: Raven Press.
3. Gasic GJ, 1984, Role of plasma, platelets, and endothelial cells in tumor metastasis. Cancer Metastasis Review, 3, 99-116.
4. Maat B and Hilgard P, 1981, Anticoagulants and experimental metastasis; evaluation and antimetastatic effects in different model systems. J Cancer Res Clinical Oncol, 101, 275-83.
5. Gorman RR, Bunting S and Miller OV, 1977, Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins, 13, 377-86.
6. Honn KV, Cicone B and Skoff A, 1981, Prostacyclin: a potent antimetastatic agent. Science, 212, 1270-2.
7. Abecassis J, Million-Collard R, Klein-Soyer C et al, 1987, Adhesion of human breast cancer cell line MCF-7 to human vascular endothelial cells in culture. Enhancement by activated platelets. Int J Cancer, 40, 525-31.
8. Constantini V, Fuschiotti P, Allegrucci M, Agnelli G, Nenci GG and Fioretti MC, 1988, Platelet-tumor cell interaction: effect of prostacyclin and a synthetic analog on metastasis formation. Cancer Chemother Pharmacol, 22, 289-93.
9. Grossi IM, Taylor JD and Honn KV, 1989, Prostacyclin and prostacyclin analogs inhibit tumor cell adhesion to substrata through inhibition of membrane expression of the integrin receptor IRGpIIb/IIIa. Proc Am Assoc Cancer Res, 30(324a), 82.
10. Sava G, Perissin L, Zorzet S, Piccini P and Giraldi T, 1989, Antimetastatic action of prostacyclin analog Iloprost in the mouse. Clin Expl Metastasis, 7, 671-8.
11. Schneider MR, Schillinger E, Schirner M, Skuballa W, Sturzebecher S and Witt W, 1990, Effects of prostacyclin analogues in in vivo tumor models. In: Sameulsson B, ed. Advances in Prostaglandin, Thromboxane, and Leukotriene Research. New York: Raven Press.
12. Kainoh M, Maruyama I, Nishio S and Nakadate T, 1991, Enhancement of betaprost sodium, a stable analogue of prostacyclin, in thrombomodulin expression on membrane surface of cultured vascular endothelial cells via increase in cyclic AMP levels. Biochem Pharmacol, 41, 1135-40.
13. Crutchley DJ, Conanan LB, Toledo AW, Solomon DE and Que BG, 1993, Effects of prostacyclin analogues on human endothelial cell tissue factor expression. Arteriosclerosis and Thrombosis, 13, 1082-9.
14. Buchanan MR, Bertomeu MC, Haas TA, Gallo S and Eltringham-Smith L, 1990, Endothelial cell 13-HODE synthesis and tumor cell endothelial cell adhesion. In: Sameulsson B, ed. Advances in Prostaglandin, Thromboxane, and Leukotriene Research. New York: Raven Press.
15. Tang DG, Diglio C and Honn KV, 1994, Activation of microvascular endothelium by eicosanoid 12(s)-hydroxy-eicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of avb3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process. Cancer Res, 54, 1119-29.
16. Iwamoto Y, Reich R, Nemeth G, Yamada Y and Martin GR, 1993, Cyclic AMP decreases chemotaxis, invasiveness, and lung colonization of H-ras transformed mouse fibroblasts. Clin Expl Metastasis, 11, 492-501.
17. Lauri D, Needham L, Martin-Padura I and Dejana E, 1991, Tumor cell adhesion to endothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor for colon carcinoma derived cells. J Natl Cancer Inst, 83, 119-23.
18. Dejana E, Martin-Padura I and Lauri D, 1992, Endothelial leukocyte adhesion molecule-1 dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type 1 carbohydrate chain. Lab Invest, 66, 324-30.
19. Pober JS, Slowik MR, De Luca LG and Ritchie AJ, 1993, Elevated cyclic AMP inhibits endothelial cell synthesis and expression of TNF-induced endothelial leukocyte adhesion molecule-1, and vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1. J Immunol, 150, 5114-23.
20. Belloni PN, Carney DH and Nicholson GL, 1992, Organ-derived endothelial cells exhibit differential responsiveness to thrombin and other growth factors. Microvascular Res, 43, 20-45.
21. McCarthy SA, Kuzu I, Gatter KC and Bicknel R, 1991, Heterogenity of the endothelial cell and its role in organ preference of tumour metastasis. Trends Pharmacol Sci, 12, 462-7.
22. Nicholson GL, 1988, Organ specificity of tumor metastasis: role of preferential adhesion, invasion, and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev, 1, 143-88.
23. Pauli BU and Lee C-L, 1988, Organ preference of metastasis: the role of organ-specifically modulated endothelial cells. Lab Invest, 58, 379-87.
24. Schirner M, Lichtner R and Schneider MR, 1994, The stable prostacyclin analogue Cicaprost inhibits metastasis to lungs and lymph nodes in the 13762NF MTLn3 rat mammary carcinoma. Clin Expl Metastasis, 12, 24-30.
25. Gimbrone MA, 1976, Culture of vascular endothelium. Prog Hemostasis Thrombosis, 3, 1-28.
26. Folkman JC, Hadenschild CC and Zetter BR, 1979, Long term culture of capillary endothelial cells. Proc Natl Acad Sci USA, 76, 5217.
27. Turner RR, Beckstead JH, Warnke RA and Wood GS, 1987, Endothelial cell phenotypic diversity. Am J Clin Pathol, 87, 569-75.
28. Swerlick RA, Lee KH, Wick TM and Lawley TJ, 1992, Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol, 148, 78-83.
29. Brouwer A, de Leeuw AM, Praaning-van Dalen DP and Knook DL, 1982, Isolation and culture of sinusoidal liver cells. In: Knook DL and Wisse E, eds. Sinusoidal Liver Cells. Amsterdam: Elsevier Biomedical Press.
30. Ryan US, Clements E, Habilston D and Ryan JW, 1978, Isolation and culture of pulmonary artery endothelial cells. Tissue Cell, 10, 535-54.
31. Davison PM, Bensch K and Karasek MA, 1980, Isolation and growth of endothelial cells from the microvessels of the newborn human foreskin in cell culture. J Invest Dermatol, 75, 316.